Please assess the completion status of the following clinical trial:

Trial Title: The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. ≥18 years of age on the day of signing the informed consent.~2. Histologically confirmed endometroid or serous endometrial cancer.~3. Scheduled to have hysterectomy at the cancer centre~4. Identifiable tumour mass on staging MRI.~5. Voluntarily agreed to participate by giving written informed consent.~Exclusion Criteria:~1. Life expectancy of \< 6 months.~2. Ferromagnetic implants, contraindicating MRI~3. Claustrophobia so unable to tolerate MRI~4. Unable to lie flat~5. Ascites sufficient to prevent patient being fitted in the scanner bore~6. Histology unlikely to show variation in TP53 status, or heavily calcified disease.~7. Radiotherapy to the abdomen or pelvis within 6 months of the screening visit.~8. Unresolved bowel obstruction.~9. Currently participating or has participated in a study with an investigational compound or device within 30 days of the start of treatment.~10. History or current evidence of any condition, therapy, or lab abnormality that might confound the results of the study, interfere with patient's participation for the full duration of the study, or is not in the best interest of the patient to participate.~11. Unlikely to comply with the requirements of the study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Endometriod (Type: None): Type I (endometrioid and mucinous carcinomas) - Magnetic Resonance Imaging (MRI) with 100% Oxygen.
- Serous (Type: None): Type II (serous and clear cell carcinomas) - Magnetic Resonance Imaging (MRI) with 100% Oxygen.

Based on this trial design, predict the completion outcome and termination type (if applicable).